Alkami Technology, Inc.
ALKT Nasdaq Services-Prepackaged Software Financials FY2019βFY2025
What Alkami Technology, Inc. does
No business description yet.
- Legal name
- ALKAMI TECHNOLOGY, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001529274-26-000009
0001529274
Revenue and margins
Alkami Technology, Inc. had $444M of revenue in fiscal 2025, up 32.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $41.4M in fiscal 2025, 9.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Alkami Technology, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 5.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Alkami Technology, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $309M | $196M | $92.1M | $94.4M | $63.5M |
| Debt incl. finance leases | $24.6M | $84.6M | $0.0M | β | β |
| Debt / equity | 0.1x | 0.3x | 0.0x | β | β |
| Interest coverage | β36.2x | β15.0x | β8.6x | β96.8x | β5.7x |
| Current ratio | 10.4x | 5.8x | 3.8x | 4.0x | 2.1x |
| Quick ratio | 10.4x | 5.8x | 3.8x | 4.0x | 2.1x |
| Total assets | $437M | $489M | $400M | $437M | $847M |
| Total liabilities | $91.9M | $155M | $74.9M | $80.2M | $485M |
| Shareholders' equity | $345M | $334M | $325M | $357M | $362M |
| Net debt (β = net cash) | β$284M | β$112M | β$92.1M | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 5 / 9 | 2 / 9 | 4 / 9 | 6 / 8 | 3 / 8 |
| Accruals ratio | β | β5.3% | β5.2% | β4.4% | β10.2% | β14.2% | β14.1% |
| Altman Z'' | β | β3.83 | 5.62 | 1.68 | 1.73 | 2.47 | β0.90 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $73.5M | $112M | $152M | $204M | $265M | $334M | $444M |
| Gross profit | $30.4M | $59.2M | $83.8M | $108M | $144M | $197M | $257M |
| Research and development | $32.7M | $40.2M | $48.8M | $69.3M | $84.7M | $96.2M | $118M |
| Operating income | β$42.5M | β$35.1M | β$42.9M | β$57.7M | β$63.7M | β$44.6M | β$53.6M |
| Interest expense | $0.1M | $0.5M | $1.2M | $3.9M | $7.4M | $0.5M | $9.5M |
| Pretax income | β | β$51.4M | β$46.7M | β$59.1M | β$62.9M | β$40.5M | β$59.0M |
| Income tax | $0.0M | $0.0M | $0.2M | β$0.5M | $0.0M | $0.3M | β$11.3M |
| Net income | β$41.9M | β$51.4M | β$46.8M | β$58.6M | β$62.9M | β$40.8M | β$47.7M |
| Net income to common | β$43.1M | β$56.6M | β$47.1M | β$58.6M | β$62.9M | β | β |
| Diluted EPS | β$9.91 | β$11.78 | β$0.73 | β$0.64 | β$0.67 | β$0.41 | β$0.46 |
| Diluted shares | 0.00B | 0.00B | 0.06B | 0.09B | 0.09B | 0.10B | 0.10B |
| Cash flow | |||||||
| Cash from operations | β$39.1M | β$38.1M | β$29.0M | β$38.0M | β$17.5M | $18.6M | $42.9M |
| Capital expenditure | $3.7M | $2.1M | $1.1M | $1.1M | $1.1M | $1.2M | $1.5M |
| Free cash flow | β$42.8M | β$40.3M | β$30.1M | β$39.1M | β$18.6M | $17.4M | $41.4M |
| Depreciation and amortization | $2.2M | $2.8M | $3.4M | $8.1M | $10.6M | $10.5M | $26.9M |
| Stock-based compensation | $1.3M | $2.0M | $14.5M | $44.6M | $51.2M | $59.4M | $76.2M |
| Acquisitions | β | $25.1M | $18.3M | $132M | $0.0M | $0.0M | $375M |
| Share buybacks | $0.0M | $3.2M | $3.5M | $0.0M | $0.0M | β | β |
| Dividends paid | $0.0M | $0.0M | $5.0M | $0.0M | $0.0M | β | β |
| Dividends and buybacks | $0.0M | $3.2M | $8.5M | $0.0M | $0.0M | β | β |
| Balance sheet | |||||||
| Cash and short-term investments | $12.0M | $167M | $309M | $196M | $92.1M | $94.4M | $63.5M |
| Total debt | β | $24.9M | $24.6M | $84.6M | $0.0M | β | β |
| Current assets | β | $193M | $345M | $242M | $149M | $181M | $187M |
| Current liabilities | β | $20.5M | $33.2M | $41.6M | $39.4M | $45.6M | $89.5M |
| Property and equipment, net | β | $10.5M | $11.8M | $13.6M | $16.9M | $22.1M | $26.7M |
| Goodwill | β | $16.2M | $48.1M | $148M | $148M | $148M | $403M |
| Intangible assets | β | $8.3M | $11.2M | $42.6M | $35.8M | $29.0M | $159M |
| Total assets | β | $249M | $437M | $489M | $400M | $437M | $847M |
| Total liabilities | β | $69.4M | $91.9M | $155M | $74.9M | $80.2M | $485M |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | β$195M | β$264M | $345M | $334M | $325M | $357M | $362M |
| Margins | |||||||
| Gross margin | 41.4% | 52.8% | 55.1% | 53.0% | 54.4% | 58.9% | 57.8% |
| Operating margin | β57.8% | β31.3% | β28.2% | β28.2% | β24.1% | β13.4% | β12.1% |
| EBITDA margin | β54.8% | β28.8% | β25.9% | β24.3% | β20.0% | β10.2% | β6.0% |
| Net margin | β56.9% | β45.8% | β30.8% | β28.7% | β23.8% | β12.2% | β10.7% |
| FCF margin | β58.2% | β35.9% | β19.8% | β19.1% | β7.0% | 5.2% | 9.3% |
| Returns | |||||||
| Return on capital | β | β | β55.9% | β20.5% | β21.6% | β | β |
| Return on capital employed | β | β15.4% | β10.6% | β12.9% | β17.7% | β11.4% | β7.1% |
| Return on equity | β | β | β115.5% | β17.3% | β19.1% | β12.0% | β13.3% |
| Return on assets | β | β20.6% | β13.7% | β12.7% | β14.2% | β9.8% | β7.4% |
| Return on tangible equity | β | β | β16.5% | β40.9% | β44.6% | β22.7% | β |
| Growth | |||||||
| Revenue growth | β | 52.5% | 35.7% | 34.2% | 29.6% | 26.1% | 32.9% |
| FCF growth | β | β | β | β | β | β | 137.7% |
| Share count change | β | 10.6% | 1,241.3% | 41.0% | 3.4% | 5.1% | 5.1% |
| Financial health | |||||||
| Debt / equity | β | β | 0.1x | 0.3x | 0.0x | β | β |
| Interest coverage | β386.7x | β71.8x | β36.2x | β15.0x | β8.6x | β96.8x | β5.7x |
| Current ratio | β | 9.4x | 10.4x | 5.8x | 3.8x | 4.0x | 2.1x |
| Quick ratio | β | 9.4x | 10.4x | 5.8x | 3.8x | 4.0x | 2.1x |
| Capital allocation | |||||||
| Capex / revenue | 5.0% | 1.9% | 0.7% | 0.5% | 0.4% | 0.4% | 0.3% |
| Stock comp / revenue | 1.7% | 1.7% | 9.6% | 21.8% | 19.3% | 17.8% | 17.2% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 5.0 | 2.0 | 4.0 | 6.0 | 3.0 |
| Altman Z'' | β | β3.8 | 5.6 | 1.7 | 1.7 | 2.5 | β0.9 |
| Accruals ratio | β | β5.3% | β5.2% | β4.4% | β10.2% | β14.2% | β14.1% |
Source: SEC EDGAR XBRL filings (CIK 0001529274). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.